A Phase 4, multicenter, prospective, non-interventional, observational study to investigate the effectiveness and safety/tolerability of perampanel when used as first adjunctive therapy in routine clinical practice in people with epilepsy: Study 512

A Phase 4, multicenter, prospective, non-interventional, observational study to investigate the effectiveness and safety/tolerability of perampanel when used as first adjunctive therapy in routine clinical practice in people with epilepsy: Study 512

IntroductionStudy 512 aimed to assess the efficacy and safety of perampanel (PER) as the first add-on therapy.MethodsIn this 12-month, prospective, observational, multicenter study, people with epilepsy (PWE) aged ≥12 years with focal-onset seizures or generalized tonic–clonic seizures (GTCS) associ...

Full description

Saved in:
Bibliographic Details
Main Authors: Sergey Burd, Giovanni Assenza, Sofia Quintas, Francisco José Gil López, Jan Wagner, Anna Lebedeva, Pavel Vlasov, Nina Pantina, Anna Patten, Samantha Goldman, Ricardo Sáinz-Fuertes, Marta Torres Arlandis, Stanislas Lagarde, Tobias Sejbaek, Vadim Kharkovsky
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Neurology
Subjects:
epilepsy
first add-on
focal epilepsy
generalized epilepsy
perampanel
real-world
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1533767/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1533767/full

Similar Items